Literature DB >> 27099976

The importance and acceptability of general and maladaptive personality trait computerized assessment feedback.

Gregory J Lengel1, Stephanie N Mullins-Sweatt1.   

Abstract

Personality traits are a useful component of clinical assessment, and have been associated with positive and negative life outcomes. Assessment of both general and maladaptive personality traits may be beneficial practice, as they may complement each other to comprehensively and accurately describe one's personality. Notably, personal preferences regarding assessment feedback have not been studied. The current study examined the acceptability of personality assessment feedback from the perspective of the examinee. Treatment-seeking participants from a university (n = 72) and Amazon.com MTurk (n = 101) completed measures of the 5-factor model and the DSM-5 alternative model of personality disorder, and were then provided feedback on their general and maladaptive personality traits. Individuals then provided feedback on which aspects they found most useful. Results demonstrated strong participant agreement that the personality trait feedback was accurate and relevant. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27099976     DOI: 10.1037/pas0000321

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  2 in total

Review 1.  A Brief but Comprehensive Review of Research on the Alternative DSM-5 Model for Personality Disorders.

Authors:  Johannes Zimmermann; André Kerber; Katharina Rek; Christopher J Hopwood; Robert F Krueger
Journal:  Curr Psychiatry Rep       Date:  2019-08-13       Impact factor: 5.285

2.  Computerized Quality of Life Assessment: A Randomized Experiment to Determine the Impact of Individualized Feedback on Assessment Experience.

Authors:  Daan Geerards; Andrea Pusic; Maarten Hoogbergen; René van der Hulst; Chris Sidey-Gibbons
Journal:  J Med Internet Res       Date:  2019-07-11       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.